Table 2 Relative frequency of the most prevalent reasons for consultation from the GP’s perspective
Total (n = 201) | Urban areas (n = 65) | Environs (n = 71) | Rural areas (n = 65) | p (C/R) | p (O/R) | |
|---|---|---|---|---|---|---|
Cardiovascular system, such as: | 14.6% | 14.8% | 14.8% | 14.3% | 0.737 | 0.749 |
high blood pressure | 6.7% | 6.8% | 6.8% | 6.4% | 0.661 | 0.639 |
coronary heart disease | 2.6% | 2.6% | 2.8% | 2.5% | 0.682 | 0.355 |
cardiac arrhythmia | 2.0% | 2.1% | 1.9% | 1.9% | 0.653 | 0.959 |
congestive heart failure | 1.9% | 1.7% | 1.8% | 2.1% | 0.169 | 0.356 |
Musculoskeletal system, such as: | 12.4% | 10.5% | 12.8% | 13.8% | 0.001 | 0.330 |
spinal disorders | 6.7% | 5.4% | 7.5% | 7.0% | 0.006 | 0.487 |
arthrosis of the large joints | 1.7% | 1.7% | 1.5% | 2.0% | 0.289 | 0.041 |
shoulder pain | 1.5% | 1.2% | 1.3% | 2.0% | 0.001 | 0.003 |
Endocrine/metabolic/nutritional, such as: | 12.2% | 12.2% | 12.5% | 11.9% | 0.816 | 0.662 |
diabetes mellitus (all types) | 3.7% | 3.5% | 3.8% | 3.9% | 0.304 | 0.838 |
lipid metabolism disorder | 2.8% | 2.6% | 3.0% | 2.7% | 0.891 | 0.544 |
weight/dietary problems | 2.6% | 2.5% | 2.8% | 2.3% | 0.791 | 0.306 |
thyroid disorder | 1.5% | 1.7% | 1.4% | 1.5% | 0.237 | 0.832 |
Respiratory system, such as: | 11.2% | 11.6% | 11.8% | 10.2% | 0.151 | 0.072 |
acute infections of the respiratory tract | 7.9% | 7.9% | 8.7% | 6.9% | 0.269 | 0.029 |
chronic obstructive pulmonary disease | 1.4% | 1.6% | 1.1% | 1.4% | 0.449 | 0.107 |
asthma | 1.0% | 1.2% | 0.9% | 1.1% | 0.499 | 0.395 |
Psychological disorders, such as: | 10.8% | 11.7% | 10.3% | 10.5% | 0.206 | 0.834 |
somatoform disorders | 3.7% | 4.0% | 3.5% | 3.6% | 0.471 | 0.858 |
mild mental disorders | 2.8% | 2.7% | 2.9% | 2.7% | 0.887 | 0.602 |
dementia | 1.6% | 1.6% | 1.4% | 1.9% | 0.622 | 0.290 |
General/unspecific disorders, such as: | 10.2% | 10.7% | 9.8% | 10.2% | 0.578 | 0.697 |
general fatigue and weakness | 3.8% | 4.3% | 3.5% | 3.5% | 0.128 | 0.982 |
vertigo | 2.0% | 2.2% | 2.0% | 1.9% | 0.310 | 0.974 |
lymph/leg oedema, chronic wounds | 1.4% | 1.2% | 1.5% | 1.7% | 0.009 | 0.316 |
adverse drug reaction | 1.2% | 1.3% | 1.1% | 1.1% | 0.422 | 0.934 |
Digestive system, such as: | 9.2% | 9.1% | 8.9% | 9.7% | 0.514 | 0.367 |
total gastrointestinal tract | 3.1% | 3.1% | 3.1% | 3.1% | 0.803 | 0.827 |
upper gastrointestinal tract | 2.9% | 2.8% | 3.0% | 3.0% | 0.571 | 0.879 |
lower gastrointestinal tract | 2.2% | 2.2% | 1.9% | 2.4% | 0.683 | 0.129 |
Social problems, such as: | 5.0% | 6.4% | 4.6% | 4.1% | 0.001 | 0.407 |
family, partnership problems | 1.3% | 1.5% | 1.2% | 1.1% | 0.059 | 0.555 |
workplace issues, unemployment | 1.2% | 1.5% | 1.1% | 0.9% | 0.001 | 0.198 |
Urological system, such as: | 3.2% | 3.2% | 3.1% | 3.4% | 0.637 | 0.420 |
urinary tract infection | 1.4% | 1.4% | 1.5% | 1.3% | 0.902 | 0.382 |
chronic kidney disease | 1.1% | 1.2% | 0.8% | 1.2% | 0.869 | 0.112 |
Skin | 2.8% | 2.4% | 3.1% | 3.0% | 0.074 | 0.759 |
Neurological system, such as: | 2.7% | 2.5% | 2.8% | 2.9% | 0.166 | 0.824 |
headache | 1.8% | 1.6% | 1.9% | 1.9% | 0.142 | 0.777 |
Ear | 1.7% | 1.4% | 1.6% | 2.0% | 0.005 | 0.140 |
Blood, blood-forming org., immune syst. | 1.2% | 1.3% | 1.2% | 1.2% | 0.544 | 0.994 |
Eye | 1.1% | 0.9% | 1.0% | 1.2% | 0.044 | 0.281 |